Dr. Marina Klein, Professor of Medicine, McGill University, and senior scientist, Infectious Diseases and Immunity in Global Health Program, RI-MUHC

Dr. Marina Klein is a senior clinician scientist and research director of the McGill University Health Centre Chronic Viral Illness Service and holds a Tier 1 Canada Research Chair. She is an internationally recognized leader in the fields of HIV and hepatitis C virus (HCV), observational research and clinical trials. She has promoted treatment access for viral hepatitis globally as governing council member of the International AIDS Society. She leads a highly successful interdisciplinary research program aimed at evaluating and implementing interventions to improve health outcomes for HIVHCV coinfected persons and influencing policy to increase access to care for vulnerable populations.

Bernard Robaire, James McGill Professor, Department of Pharmacology and Therapeutics, McGill University, and investigator, Child Health and Human Development Program, RI-MUHC

Bernard Robaire, PhD, is a world leader in the field of male reproduction and medicine. His groundbreaking research demonstrated that paternal exposure to some therapeutic agents and environmental chemicals may alter the quality of sperm chromatin and have adverse effects on offspring. Importantly, he established that aging of the father is associated with decreased sperm quality and that this has consequences for progeny outcome. His pioneering studies of androgen action revealed the pathway by which androgens act rapidly on target cells. His fundamental studies on the impact of steroid combinations on spermatogenesis are the basis for developing a male contraceptive.